CLBT — Cellebrite DI Ltd.

Is CLBT overbought or oversold? Here is the current MarketMoodz read.

Technology · Software - Infrastructure

Neutral As of October 3, 2026

Cellebrite DI Ltd. (CLBT) currently reads Neutral on the MarketMoodz overbought/oversold meter, as of October 3, 2026. The Technology name (Software - Infrastructure) last closed at $11.07. The rating moved from Oversold to Neutral on October 3, 2026.

AI analysis

Cellebrite DI Ltd. is a specialist in digital-forensics and investigative software with a durable base of law-enforcement and commercial customers and a growing subscription/analytics mix that supports revenue visibility. Product strength and a roadmap emphasizing analytics/AI offer medium-term upside through higher ARPU and cross-sell, but near-term momentum is muted given defensive market sentiment and a lack of immediate new catalysts. Key vulnerabilities include regulatory and privacy scrutiny, encryption trends that can degrade product utility, customer concentration in public budgets, and reputational risk tied to sensitive government work. Performance over the next month is likely to track broader risk-off flows and discrete company execution on AI features and contract wins.

Key factors

  • Leading position in digital-forensics and mobile/device intelligence software with established law-enforcement and enterprise customer base
  • Recurring revenue mix (maintenance, subscriptions, analytics services) supports revenue visibility and margin stability
  • Product roadmap includes advanced analytics and AI-driven triage capabilities that could increase ARPU and cross-sell opportunities
  • Exposure to government and corporate investigation budgets provides a stable demand backbone but creates some cyclicality tied to public budgets and procurement cycles
  • Relatively lean cost structure and historically positive gross margins versus smaller pure-software peers
  • Limited publicly available recent positive catalysts and muted market sentiment amid broader risk-off conditions

Risks

  • Regulatory, privacy, and civil-liberties scrutiny that could restrict product features, sales channels, or create litigation exposure
  • Technological headwinds from stronger encryption, OS-level protections, or OEM cooperation that reduce product effectiveness
  • Customer concentration and dependence on public-sector budgets that can be affected by macro fiscal tightening or geopolitical events
  • Reputational risk tied to sensitive government work that could impact commercial demand or lead to contractual restrictions
  • Competition from other forensics vendors, open-source tools, and large cloud providers integrating investigative tooling
  • Operational/execution risk on scaling AI/analytics features and converting R&D into sustainable incremental revenue

See today's live rating, score and targets

Members see the live hourly rating for CLBT — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.